<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6614">
  <stage>Registered</stage>
  <submitdate>21/07/2017</submitdate>
  <approvaldate>21/07/2017</approvaldate>
  <nctid>NCT03228901</nctid>
  <trial_identification>
    <studytitle>Oxytocin and Non-verbal Communication</studytitle>
    <scientifictitle>Exploring the Effects of Oxytocin on Non-verbal Communication</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>IG15-B052</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Social Interaction</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Oxytocin
Treatment: drugs - Placebos

Experimental: Oxytocin - 24IU Syntocinon, delivered in a single nose via a nasal spray

Placebo Comparator: Placebo - Matched nasal spray


Treatment: drugs: Oxytocin
Administration of the hormone oxytocin

Treatment: drugs: Placebos


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Non-verbal communication - Based on coding the video-recorded interaction between two strangers, using a coding scheme by Gonzaga et al. (for affiliative and sexual cues)</outcome>
      <timepoint>Measured in the interaction which commenced 45mins after drug administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Ratings of the person participants interacted with - Positivity or sexual attraction towards the other participant in the conversation (as measured using visual analogue scales based on person perception studies)</outcome>
      <timepoint>Measured following the interaction (which commenced 45 mins after drug administration)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  healthy</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  pregnant;

          -  history of epilepsy, severe depression, severe anxiety, or psychosis;

          -  smoking more than 15 cigarettes a day;

          -  addicted to illegal substances.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Basic Science</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>104</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/07/2009</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>University of New South Wales - Sydney</hospital>
    <postcode>2052 - Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Yale-NUS College</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this protocol registration, the investigators plan a secondary data analysis of a dataset
      to explore the effects of intra-nasal oxytocin on the non-verbal expression of affiliation.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT03228901</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>